Lakshmi Ganapathi, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance Abuse, Intravenous | 3 | 2023 | 525 | 1.690 |
Why?
|
| Drug Users | 1 | 2023 | 134 | 0.780 |
Why?
|
| Schistosoma haematobium | 1 | 2015 | 11 | 0.540 |
Why?
|
| Schistosomiasis haematobia | 1 | 2015 | 15 | 0.540 |
Why?
|
| Transplantation | 1 | 2017 | 217 | 0.530 |
Why?
|
| Buprenorphine | 1 | 2023 | 640 | 0.510 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2015 | 90 | 0.510 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2023 | 941 | 0.500 |
Why?
|
| Tuberculosis, Pleural | 1 | 2014 | 12 | 0.490 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2015 | 172 | 0.480 |
Why?
|
| Ethics, Medical | 1 | 2019 | 792 | 0.480 |
Why?
|
| Hematuria | 1 | 2015 | 235 | 0.480 |
Why?
|
| Urine | 1 | 2015 | 370 | 0.470 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 1071 | 0.440 |
Why?
|
| Cytomegalovirus Infections | 1 | 2019 | 820 | 0.440 |
Why?
|
| Physician's Role | 1 | 2019 | 943 | 0.420 |
Why?
|
| HIV Infections | 3 | 2023 | 16718 | 0.380 |
Why?
|
| Quinolines | 1 | 2015 | 732 | 0.370 |
Why?
|
| Health Services Needs and Demand | 1 | 2017 | 1411 | 0.340 |
Why?
|
| Organ Transplantation | 1 | 2019 | 1139 | 0.340 |
Why?
|
| Imidazoles | 1 | 2015 | 1206 | 0.340 |
Why?
|
| Leukocytes | 1 | 2015 | 2043 | 0.290 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 3772 | 0.280 |
Why?
|
| India | 2 | 2021 | 2197 | 0.240 |
Why?
|
| Cytokines | 2 | 2016 | 7322 | 0.230 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 5137 | 0.210 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2291 | 0.210 |
Why?
|
| Harm Reduction | 1 | 2021 | 129 | 0.180 |
Why?
|
| Needle Sharing | 1 | 2019 | 24 | 0.170 |
Why?
|
| Pediatrics | 1 | 2014 | 3475 | 0.170 |
Why?
|
| Unsafe Sex | 1 | 2019 | 220 | 0.150 |
Why?
|
| Emigration and Immigration | 1 | 2019 | 404 | 0.140 |
Why?
|
| Eritrea | 1 | 2014 | 4 | 0.130 |
Why?
|
| Laos | 1 | 2014 | 29 | 0.130 |
Why?
|
| Public Policy | 1 | 2019 | 572 | 0.130 |
Why?
|
| Cytomegalovirus | 1 | 2019 | 732 | 0.130 |
Why?
|
| Child | 8 | 2023 | 77709 | 0.130 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2016 | 708 | 0.120 |
Why?
|
| Steroids | 1 | 2019 | 930 | 0.120 |
Why?
|
| Cambodia | 1 | 2014 | 191 | 0.120 |
Why?
|
| Internship and Residency | 1 | 2014 | 5788 | 0.120 |
Why?
|
| Training Support | 1 | 2014 | 113 | 0.120 |
Why?
|
| Adolescent | 6 | 2021 | 85781 | 0.110 |
Why?
|
| Risk-Taking | 1 | 2019 | 986 | 0.110 |
Why?
|
| DNA, Viral | 1 | 2019 | 2225 | 0.110 |
Why?
|
| Toll-Like Receptors | 1 | 2016 | 592 | 0.110 |
Why?
|
| Kenya | 1 | 2014 | 685 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5442 | 0.100 |
Why?
|
| Th1 Cells | 1 | 2016 | 1057 | 0.100 |
Why?
|
| Th2 Cells | 1 | 2016 | 1061 | 0.100 |
Why?
|
| Adjuvants, Immunologic | 1 | 2016 | 1000 | 0.090 |
Why?
|
| Salmonella typhi | 1 | 2012 | 201 | 0.090 |
Why?
|
| Typhoid Fever | 1 | 2012 | 197 | 0.090 |
Why?
|
| Sexual Behavior | 1 | 2019 | 2057 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 1972 | 0.080 |
Why?
|
| Fetal Blood | 1 | 2015 | 1318 | 0.080 |
Why?
|
| Humans | 15 | 2023 | 744343 | 0.080 |
Why?
|
| International Cooperation | 1 | 2014 | 1420 | 0.080 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 1265 | 0.070 |
Why?
|
| Risk | 1 | 2019 | 9687 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2019 | 2987 | 0.070 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 3674 | 0.070 |
Why?
|
| Boston | 1 | 2019 | 9313 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2015 | 4217 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4204 | 0.070 |
Why?
|
| Parents | 1 | 2019 | 3407 | 0.070 |
Why?
|
| Qualitative Research | 1 | 2014 | 2682 | 0.070 |
Why?
|
| Diarrhea | 1 | 2012 | 1348 | 0.060 |
Why?
|
| Male | 7 | 2021 | 350118 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 6171 | 0.060 |
Why?
|
| Dendritic Cells | 1 | 2015 | 2725 | 0.060 |
Why?
|
| Curriculum | 1 | 2017 | 3605 | 0.060 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2014 | 1832 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2012 | 1563 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 4149 | 0.050 |
Why?
|
| Logistic Models | 2 | 2014 | 13408 | 0.050 |
Why?
|
| Prevalence | 1 | 2019 | 15226 | 0.050 |
Why?
|
| Age Factors | 1 | 2019 | 18370 | 0.050 |
Why?
|
| Developing Countries | 1 | 2014 | 2815 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2017 | 4687 | 0.050 |
Why?
|
| Female | 6 | 2021 | 380194 | 0.050 |
Why?
|
| Pandemics | 1 | 2021 | 8388 | 0.050 |
Why?
|
| Incidence | 1 | 2019 | 20947 | 0.050 |
Why?
|
| United States | 2 | 2019 | 69872 | 0.050 |
Why?
|
| Infant | 2 | 2019 | 35136 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2023 | 77449 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2019 | 41006 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2016 | 25625 | 0.040 |
Why?
|
| Vancomycin | 1 | 2021 | 501 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 25043 | 0.040 |
Why?
|
| Aging | 1 | 2016 | 8664 | 0.040 |
Why?
|
| Adult | 4 | 2019 | 214055 | 0.030 |
Why?
|
| Young Adult | 2 | 2019 | 56430 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2023 | 1775 | 0.030 |
Why?
|
| Pregnancy | 1 | 2015 | 29144 | 0.030 |
Why?
|
| Serotyping | 1 | 2012 | 338 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 20129 | 0.020 |
Why?
|
| Bangladesh | 1 | 2012 | 687 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 7181 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2023 | 9274 | 0.020 |
Why?
|
| Bacteremia | 1 | 2012 | 962 | 0.020 |
Why?
|
| Hospitalization | 1 | 2023 | 10262 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 168757 | 0.010 |
Why?
|
| Hospitals | 1 | 2012 | 3952 | 0.010 |
Why?
|